Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.1M Sell
75,720
-5,882
-7% -$1.27M 0.47% 52
2026
Q1
$17.7M Sell
81,602
-480
-0.6% -$106K 0.49% 49
2025
Q4
$18.8M Sell
82,082
-9,620
-10% -$2.19M 0.52% 46
2025
Q3
$21.2M Sell
91,702
-3,049
-3% -$621K 0.59% 41
2025
Q2
$17.6M Buy
94,751
+12,180
+15% +$2.26M 0.52% 46
2025
Q1
$17.3M Sell
82,571
-3,270
-4% -$636K 0.6% 40
2024
Q4
$15.3M Sell
85,841
-672
-0.8% -$124K 0.52% 43
2024
Q3
$17.1M Sell
86,513
-464
-0.5% -$86.6K 0.58% 40
2024
Q2
$14.9M Sell
86,977
-1,705
-2% -$282K 0.56% 45
2024
Q1
$16.1M Buy
88,682
+53,363
+151% +$9.2M 0.61% 37
2023
Q4
$5.47M Sell
35,319
-62,181
-64% -$9.07M 0.31% 87
2023
Q3
$14.5M Buy
97,500
+1,303
+1% +$191K 0.63% 36
2023
Q2
$13M Sell
96,197
-1,182
-1% -$173K 0.54% 46
2023
Q1
$15.5M Sell
97,379
-355
-0.4% -$54.3K 0.67% 33
2022
Q4
$15.8M Buy
97,734
+62,169
+175% +$9.53M 0.7% 31
2022
Q3
$4.77M Sell
35,565
-63,801
-64% -$9.16M 0.32% 90
2022
Q2
$15.2M Sell
99,366
-1,778
-2% -$272K 0.67% 33
2022
Q1
$16.4M Sell
101,144
-6,308
-6% -$916K 0.62% 37
2021
Q4
$14.5M Sell
107,452
-12,893
-11% -$1.52M 0.52% 50
2021
Q3
$13M Buy
120,345
+12,531
+12% +$1.43M 0.5% 57
2021
Q2
$12.1M Sell
107,814
-1,633
-1% -$184K 0.45% 63
2021
Q1
$11.8M Buy
+109,447
New +$11.7M 0.47% 57
2020
Q3
$11.1M Sell
126,945
-1,300
-1% -$122K 0.51% 56
2020
Q2
$12.6M Buy
128,245
+54,010
+73% +$4.76M 0.62% 44
2020
Q1
$5.66M Buy
74,235
+4,726
+7% +$403K 0.33% 82
2019
Q4
$6.15M Buy
69,509
+573
+0.8% +$47.6K 0.28% 89
2019
Q3
$5.22M Buy
68,936
+3,645
+6% +$250K 0.26% 94
2019
Q2
$4.75M Buy
65,291
+696
+1% +$54.7K 0.23% 98
2019
Q1
$5.21M Buy
64,595
+9,103
+16% +$745K 0.26% 94
2018
Q4
$5.12M Sell
55,492
-81
-0.1% -$7.12K 0.3% 78
2018
Q3
$5.26M Sell
55,573
-1,368
-2% -$130K 0.26% 95
2018
Q2
$5.28M Buy
56,941
+467
+0.8% +$45.6K 0.27% 91
2018
Q1
$5.35M Buy
56,474
+23,377
+71% +$2.57M 0.27% 95
2017
Q4
$3.2M Sell
33,097
-25,188
-43% -$2.37M 0.22% 102
2017
Q3
$5.18M Buy
58,285
+4,577
+9% +$348K 0.27% 92
2017
Q2
$3.89M Sell
53,708
-260
-0.5% -$17.5K 0.21% 107
2017
Q1
$3.52M Sell
53,968
-306
-0.6% -$19.2K 0.19% 113
2016
Q4
$3.4M Sell
54,274
-12
-0% -$732 0.19% 108
2016
Q3
$3.42M Buy
54,286
+365
+0.7% +$23.6K 0.2% 107
2016
Q2
$3.34M Sell
53,921
-2,854
-5% -$174K 0.2% 111
2016
Q1
$3.24M Buy
56,775
+19,873
+54% +$1.11M 0.19% 115
2015
Q4
$2.19M Sell
36,902
-30,575
-45% -$1.76M 0.13% 152
2015
Q3
$3.67M Sell
67,477
-260
-0.4% -$16.9K 0.22% 100
2015
Q2
$4.55M Buy
67,737
+8,447
+14% +$551K 0.25% 92
2015
Q1
$3.47M Buy
59,290
+19,891
+50% +$1.2M 0.19% 114
2014
Q4
$2.58M Sell
39,399
-701
-2% -$44.2K 0.14% 142
2014
Q3
$2.32M Sell
40,100
-442
-1% -$24.5K 0.13% 143
2014
Q2
$2.29M Buy
40,542
+220
+0.5% +$11.5K 0.13% 142
2014
Q1
$2.07M Sell
40,322
-13,885
-26% -$702K 0.12% 148
2013
Q4
$2.86M Sell
54,207
-570
-1% -$28K 0.16% 121
2013
Q3
$2.45M Sell
54,777
-566
-1% -$25.1K 0.15% 125
2013
Q2
$2.29M Buy
+55,343
New +$2.42M 0.15% 125

Other funds holding ABBV

WesBanco Bank's ABBV Position: Q2 2026 in Review

WesBanco Bank reduced its AbbVie (ABBV) stake by 7.2% in Q2 2026, selling an estimated $1.27M and leaving 75,720 shares worth $19.1M. The position accounts for 0.47% of the portfolio, ranked #52.

WesBanco Bank first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $21.2M in Q3 2025. 2,119 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • WesBanco Bank held 75,720 shares of AbbVie worth $19.1M as of Q2 2026.
  • WesBanco Bank sold 5,882 AbbVie shares in Q2 2026, an estimated $1.27M.
  • AbbVie made up 0.47% of WesBanco Bank's portfolio in Q2 2026, its #52 holding.
  • WesBanco Bank first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
  • WesBanco Bank's AbbVie position peaked at $21.2M in Q3 2025.
  • 2,119 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on WesBanco Bank's 13F filing for Q2 2026, filed 28 Jul 2026.